Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
10K
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
-620K
-
Total reported value, excl. options
-
$756M
-
Value change
-
-$27.4M
-
Number of buys
-
51
-
Number of sells
-
-41
-
Price
-
$25.65
Significant Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q2 2021
100 filings reported holding ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q2 2021.
iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.42M shares), BOXER CAPITAL, LLC (4.35M shares), MPM ASSET MANAGEMENT LLC (3.67M shares), MPM Oncology Impact Management LP (2.34M shares), RTW INVESTMENTS, LP (1.72M shares), BlackRock Inc. (1.52M shares), ALLIANCEBERNSTEIN L.P. (1.36M shares), JANUS HENDERSON GROUP PLC (1.06M shares), EcoR1 Capital, LLC (1.04M shares), and CITADEL ADVISORS LLC (994K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.